PE20030987A1 - Compuestos de 2-pirimidona triciclica como inhibidores de transcriptasa inversa del vih - Google Patents
Compuestos de 2-pirimidona triciclica como inhibidores de transcriptasa inversa del vihInfo
- Publication number
- PE20030987A1 PE20030987A1 PE2003000060A PE2003000060A PE20030987A1 PE 20030987 A1 PE20030987 A1 PE 20030987A1 PE 2003000060 A PE2003000060 A PE 2003000060A PE 2003000060 A PE2003000060 A PE 2003000060A PE 20030987 A1 PE20030987 A1 PE 20030987A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alcoxy
- ocf3
- tricyclic
- reverse transcriptase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A COMPUESTOS DE 2-PIRIMIDONA TRICICLICA DE FORMULA I DONDE A ES UN ANILLO SELECCIONADO DEL GRUPO a, GRUPO b DONDE p ES O, S; Q ES O, NH; Ra ES H, CN, ALQUILO C1-C4, ALQUENILO C1-C4, ALQUINILO C1-C4, OH, (ALQUIL C1-C4 ATOMOS DE CARBONO)-O-, (ALQUIL C1-C4)-NH-, NH2; Fb ES H, ALQUILO C1-C4, ALQUENILO C1-C4, ALQUINILO C1-C4, ENTRE OTROS; W ES N, CR3; X ES N, CR3a; Y ES N, CR3b; Z ES N, CR3c CON LA CONDICION DE QUE SI DOS W, X, Y y Z SON N ENTONCES LOS RESTANTES SON DIFERENTES A NITROGENO; R1 ES CICLOPROPILO, HIDROXIMETILO, CN, ALQUILO C1-C4, R2 ES METILO, ALQUILO C1-C6, HALOALQUILO C2-C6, ALQUENILO C2-C5, ALQUINILO C2-C5, ENTRE OTROS; R3 ES H, ALQUILO C1-C4, -OH, ALCOXI C1-C4, OCF3, CF3, F, Cl, ENTRE OTROS; R3a ES H, ALQUILO C1-C4, OH, ALCOXI C1-C4, OCF3, CF3, F, ENTRE OTROS; R3b ES H, ALQUILO C1-C4, -OH, ALCOXI C1-C4, OCF3, ENTRE OTROS; R3c ES H, ALQUILO C1-C4, -OH, ALCOXI C1-C4, OCF3, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 10-BUTIL-8-CLORO-10-(TRIFLUOROMETIL)-5,10-DIHIDROPIRIMIDO[5,4-b]QUINOLIN-4-(3H)-ONA, 10-BUTIL-8-CIANO-10-(TRIFLUOROMETIL)-5,10-DIHIDROPIRIMIDO[5,4-b]QUINOLIN-4-(3H)-ONA, 8-CLORO-10-(ISOPROPOXIMETIL)-10-(TRIFLUOROMETIL)-5,10-DIHIDROPIRIMIDO[5,4-b]QUINOLIN-4-(3H)-ONA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE TRANSCRIPTASA INVERSA DEL VIH
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34964102P | 2002-01-18 | 2002-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030987A1 true PE20030987A1 (es) | 2003-11-15 |
Family
ID=27613304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000060A PE20030987A1 (es) | 2002-01-18 | 2003-01-20 | Compuestos de 2-pirimidona triciclica como inhibidores de transcriptasa inversa del vih |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6844340B2 (es) |
| EP (1) | EP1474424A4 (es) |
| JP (1) | JP2005519910A (es) |
| KR (1) | KR20040077735A (es) |
| CN (1) | CN1642954A (es) |
| AR (1) | AR038164A1 (es) |
| BR (1) | BR0306927A (es) |
| CA (1) | CA2473420A1 (es) |
| CO (1) | CO5590961A2 (es) |
| HR (1) | HRP20040643A2 (es) |
| IL (1) | IL162743A0 (es) |
| IS (1) | IS7341A (es) |
| MX (1) | MXPA04006948A (es) |
| NO (1) | NO20043424L (es) |
| PE (1) | PE20030987A1 (es) |
| PL (1) | PL371418A1 (es) |
| RU (1) | RU2004125151A (es) |
| TW (1) | TW200306192A (es) |
| WO (1) | WO2003062238A1 (es) |
| YU (1) | YU62504A (es) |
| ZA (1) | ZA200405139B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7169932B2 (en) | 2001-06-11 | 2007-01-30 | Pfizer Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| US7094909B2 (en) | 2001-06-11 | 2006-08-22 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| HN2002000136A (es) | 2001-06-11 | 2003-07-31 | Basf Ag | Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis |
| TW200306192A (en) * | 2002-01-18 | 2003-11-16 | Bristol Myers Squibb Co | Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| AR039540A1 (es) * | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | Compuestos microbicidas con contenido de pirimidina o triazina |
| US20070021449A1 (en) | 2003-02-07 | 2007-01-25 | Jan Heeres | Pyrimidine derivatives for the prevention of hiv infection |
| WO2008004100A2 (en) | 2006-07-05 | 2008-01-10 | Pfizer Products Inc. | Therapeutic compounds |
| US20080119552A1 (en) * | 2006-11-17 | 2008-05-22 | Novus International Inc. | Matrix-embedded compositions having organic acids and fatty acids |
| JP5406215B2 (ja) | 2008-01-25 | 2014-02-05 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | ＴＮＦ−α合成の調節因子及びＰＤＥ４阻害剤としての三環系化合物 |
| US20120316161A1 (en) | 2009-12-23 | 2012-12-13 | Katholieke Universiteit Leuven | Novel antiviral compounds |
| EP2640705A2 (en) | 2010-11-15 | 2013-09-25 | Katholieke Universiteit Leuven | Novel antiviral compounds |
| CA2817896A1 (en) | 2010-11-15 | 2012-05-24 | Viiv Healthcare Uk Limited | Inhibitors of hiv replication |
| CN103130787B (zh) * | 2011-11-24 | 2015-06-10 | 南开大学 | 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593337B1 (en) * | 1999-10-19 | 2003-07-15 | Bristol-Myers Squibb Pharma Company | Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| US6596729B2 (en) | 2000-07-20 | 2003-07-22 | Bristol-Myers Squibb Company | Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| TW200306192A (en) * | 2002-01-18 | 2003-11-16 | Bristol Myers Squibb Co | Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
-
2003
- 2003-01-14 TW TW092100706A patent/TW200306192A/zh unknown
- 2003-01-16 KR KR10-2004-7011080A patent/KR20040077735A/ko not_active Application Discontinuation
- 2003-01-16 MX MXPA04006948A patent/MXPA04006948A/es unknown
- 2003-01-16 RU RU2004125151/04A patent/RU2004125151A/ru not_active Application Discontinuation
- 2003-01-16 JP JP2003562115A patent/JP2005519910A/ja not_active Withdrawn
- 2003-01-16 YU YU62504A patent/YU62504A/sh unknown
- 2003-01-16 IL IL16274303A patent/IL162743A0/xx unknown
- 2003-01-16 CA CA002473420A patent/CA2473420A1/en not_active Abandoned
- 2003-01-16 PL PL03371418A patent/PL371418A1/xx not_active Application Discontinuation
- 2003-01-16 CN CNA038060566A patent/CN1642954A/zh active Pending
- 2003-01-16 BR BR0306927-3A patent/BR0306927A/pt not_active IP Right Cessation
- 2003-01-16 WO PCT/US2003/001604 patent/WO2003062238A1/en not_active Application Discontinuation
- 2003-01-16 EP EP03702165A patent/EP1474424A4/en not_active Withdrawn
- 2003-01-17 US US10/346,613 patent/US6844340B2/en not_active Expired - Lifetime
- 2003-01-17 AR ARP030100142A patent/AR038164A1/es not_active Application Discontinuation
- 2003-01-20 PE PE2003000060A patent/PE20030987A1/es not_active Application Discontinuation
-
2004
- 2004-06-28 ZA ZA200405139A patent/ZA200405139B/en unknown
- 2004-06-30 IS IS7341A patent/IS7341A/is unknown
- 2004-07-13 HR HR20040643A patent/HRP20040643A2/hr not_active Application Discontinuation
- 2004-07-15 US US10/891,974 patent/US7186830B2/en not_active Expired - Lifetime
- 2004-07-16 CO CO04068142A patent/CO5590961A2/es not_active Application Discontinuation
- 2004-08-17 NO NO20043424A patent/NO20043424L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL162743A0 (en) | 2005-11-20 |
| US7186830B2 (en) | 2007-03-06 |
| NO20043424L (no) | 2004-08-18 |
| CA2473420A1 (en) | 2003-07-31 |
| US20030162800A1 (en) | 2003-08-28 |
| US20040266778A1 (en) | 2004-12-30 |
| HRP20040643A2 (en) | 2005-04-30 |
| BR0306927A (pt) | 2004-11-09 |
| TW200306192A (en) | 2003-11-16 |
| RU2004125151A (ru) | 2006-02-20 |
| CO5590961A2 (es) | 2005-12-30 |
| EP1474424A4 (en) | 2005-12-28 |
| WO2003062238A1 (en) | 2003-07-31 |
| CN1642954A (zh) | 2005-07-20 |
| EP1474424A1 (en) | 2004-11-10 |
| YU62504A (sh) | 2006-08-17 |
| IS7341A (is) | 2004-06-30 |
| PL371418A1 (en) | 2005-06-13 |
| ZA200405139B (en) | 2006-02-22 |
| KR20040077735A (ko) | 2004-09-06 |
| MXPA04006948A (es) | 2004-12-06 |
| JP2005519910A (ja) | 2005-07-07 |
| AR038164A1 (es) | 2004-12-29 |
| US6844340B2 (en) | 2005-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030987A1 (es) | Compuestos de 2-pirimidona triciclica como inhibidores de transcriptasa inversa del vih | |
| AR075005A1 (es) | Derivados de sulfonamida | |
| CO5200848A1 (es) | Derivados de 3(5)-ureido-pirazol, proceso para su prepa- racion y su utilizacion como agentes antitumorales | |
| PE20151787A1 (es) | Derivados de 5-fenoxi-3h-pirimidin-4-ona y su uso como inhibidores de la transcriptasa inversa del vih | |
| CO6220931A2 (es) | Inhibidores de serina proteasas para el tratamiento de infecciones de vhc | |
| PE20131197A1 (es) | Compuestos de pirazolopirimidina como inhibidores de jak y composiciones farmaceuticas que los contienen | |
| PE20061335A1 (es) | Compuestos derivados de benzodioxano y benzodioxolano como moduladores del receptor 5-ht2c | |
| PE20020508A1 (es) | DERIVADOS DE PIRIDINA COMO INHIBIDORES DE LA ACTIVIDAD DE LA QUINASA IkB ß | |
| ECSP034563A (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos | |
| PE20040479A1 (es) | Inhibidores de proteasa del vih y composiciones que los contienen | |
| CO5560560A2 (es) | Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad | |
| AR039468A1 (es) | Pirazolo-pirimidin-4-onas sustituidas | |
| PE20050013A1 (es) | Composiciones farmaceuticas como inhibidores de la proteasa del virus de la hepatitis c | |
| PE20120172A1 (es) | Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide | |
| PE20040832A1 (es) | Derivados de indolil pirazinona | |
| UY28466A1 (es) | Derivados de piperazina | |
| AR045529A1 (es) | Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi | |
| PE20020735A1 (es) | Derivados de quinazolona como antagonistas de receptores adrenergicos alfa-1a/b | |
| CO6321261A2 (es) | Derivados biciclicos heterociclicos o espirobiciclicos heterociclicos enlazados de pirazolo [1,5-a] pirimidinas procedimientos para su preparacion y usos de los mismos | |
| HUP0402588A2 (hu) | Kinazolinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
| AR052682A1 (es) | DERIVADOS DE 5, 6, 7, 8 - TETRAHIDROTIEN[2, 3 - B]QUINOLINA uTILES PARA INHIBIR LA ACTIVIDAD DE QUINESINA DE KSP, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS. | |
| PE20010696A1 (es) | Compuestos agonistas del receptor de adenosina a3 para el tratamiento de la isquemia | |
| PE20061424A1 (es) | Compuestos triciclicos de base 1,6-dihidro-1-3,5,6-tetraaza-as-indaceno y composiciones farmaceuticas que comprenden los mismos | |
| AR070221A1 (es) | Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas. | |
| AR086468A1 (es) | Compuestos heterociclos biciclicos y sus usos en terapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |